Fresh buying in index pivotals pushed the key benchmark indices to intraday high in afternoon trade. At 13:21 IST, the barometer index, the S&P BSE Sensex, was up 113.37 points or 0.32% at 35,467.45. The Nifty 50 index was up 37.10 points or 0.35% at 10,665.70.
Investors are cautious ahead of the expiry of futures and options (F&O) contracts on Thursday and the release of India's gross domestic product data for the September quarter on Friday.
Among secondary barometers, the BSE Mid-Cap index was up 0.14%. The BSE Small-Cap index was up 0.33%.
The market breadth, indicating the overall health of the market, was negative. On BSE, 1117 shares rose and 1251 shares fell. A total of 140 shares were unchanged.
Infosys (up 2.01%), Reliance Industries (up 1.54%), NTPC (up 1.25%), State Bank of India (up 1.17%) and TCS (up 1.15%) edged higher from the Sensex pack.
Hero MotoCorp (down 2.09%), Bajaj Auto (down 2.07%) and Asian Paints (down 1.36%) edged lower from the Sensex pack.
Sun Pharmaceutical Industries lost 4.89%. Sun Pharmaceutical Industries (Sun Pharma) including its subsidiaries and/or associate companies, announced that Sun Pharma has entered into a definitive agreement to acquire Pola Pharma Inc. (Pola Pharma), a Japanese pharmaceutical company engaged in research and development, manufacture, sale and distribution of branded and generic products in Japan. The portfolio of Pola Pharma primarily comprises dermatology products. The transaction is expected to close on or before 31 January 2019, subject to completion of closing conditions. The announcement was made after market hours yesterday, 26 November 2018.
In a separate announcement made after market hours yesterday, 26 November 2018, Sun Pharma and one of its wholly-owned subsidiaries entered into settlements with certain plaintiffs in the In re Modafinil Antitrust Litigation matter pending in the United States District Court for the Eastern District of Pennsylvania. The settlements extend to all claims brought by the Direct Purchaser Plaintiffs. The terms of the settlements are confidential, Sun Pharma said.
Overseas, Asian shares were mixed on Tuesday after US President Donald Trump quashed hopes of a trade truce with China, dampening risk appetite across the region.
In a media interview, Trump said it is highly unlikely that he would delay an increase in tariffs from 10% to 25% on 1 January 2019. His comments came days before the G-20 summit in Buenos Aires, Argentina, where he is set to meet Xi for trade talks. Many investors and decision makers are hoping that the summit will diffuse trade tensions between the US and China after each country applied additional tariffs on billions of dollars' worth of each other's imports.
US stocks closed higher Monday as retail shares rallied on expectations of strong sales as shoppers went hunting for deals on Cyber Monday. Stable oil prices and global equities gains also soothed sentiment after a bruising week of losses.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
